Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Asset Utilization Ratio (2016 - 2025)

Heron Therapeutics (HRTX) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.61 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 3.47% year-over-year to 0.61, compared with a TTM value of 0.61 through Dec 2025, down 3.47%, and an annual FY2025 reading of 0.63, changed 0.03% over the prior year.
  • Asset Utilization Ratio was 0.61 for Q4 2025 at Heron Therapeutics, down from 0.64 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.64 in Q3 2025 and bottomed at 0.23 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.48, with a median of 0.56 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio dropped 15.85% in 2021, then skyrocketed 67.06% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.26 in 2021, then skyrocketed by 56.94% to 0.41 in 2022, then soared by 36.59% to 0.56 in 2023, then increased by 13.02% to 0.64 in 2024, then decreased by 3.47% to 0.61 in 2025.
  • Business Quant data shows Asset Utilization Ratio for HRTX at 0.61 in Q4 2025, 0.64 in Q3 2025, and 0.64 in Q2 2025.